ANTX Annual Shareholders Equity
$124.70 M
+$29.33 M+30.75%
31 December 2023
Summary:
As of January 20, 2025, ANTX annual stockholders equity is $124.70 million, with the most recent change of +$29.33 million (+30.75%) on December 31, 2023. During the last 3 years, it has risen by +$145.02 million (+713.72%). ANTX annual shareholders equity is now at all-time high.ANTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANTX Quarterly Shareholders Equity
$87.67 M
-$10.68 M-10.86%
30 September 2024
Summary:
As of January 20, 2025, ANTX quarterly stockholders equity is $87.67 million, with the most recent change of -$10.68 million (-10.86%) on September 30, 2024. Over the past year, it has dropped by -$22.93 million (-20.73%). ANTX quarterly shareholders equity is now -36.91% below its all-time high of $138.97 million, reached on September 30, 2023.ANTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.8% | -20.7% |
| 3 y3 years | +713.7% | -20.7% |
| 5 y5 years | +713.7% | -20.7% |
ANTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.4% | -36.9% | +41.6% |
| 5 y | 5-year | at high | +713.7% | -36.9% | +41.6% |
| alltime | all time | at high | +713.7% | -36.9% | +41.6% |
AN2 Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $87.67 M(-10.9%) |
| June 2024 | - | $98.35 M(-11.1%) |
| Mar 2024 | - | $110.60 M(-11.3%) |
| Dec 2023 | $124.70 M(+30.8%) | $124.70 M(-10.3%) |
| Sept 2023 | - | $138.97 M(+58.3%) |
| June 2023 | - | $87.76 M(+6.4%) |
| Mar 2023 | - | $82.52 M(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $95.37 M(+54.1%) | $95.37 M(-9.7%) |
| Sept 2022 | - | $105.57 M(-8.9%) |
| June 2022 | - | $115.86 M(+0.4%) |
| Mar 2022 | - | $115.41 M(+86.4%) |
| Dec 2021 | $61.91 M(-404.7%) | - |
| Dec 2021 | - | $61.91 M |
| Dec 2020 | -$20.32 M | - |
FAQ
- What is AN2 Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for AN2 Therapeutics?
- What is AN2 Therapeutics annual shareholders equity year-on-year change?
- What is AN2 Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly shareholders equity year-on-year change?
What is AN2 Therapeutics annual stockholders equity?
The current annual shareholders equity of ANTX is $124.70 M
What is the all time high annual shareholders equity for AN2 Therapeutics?
AN2 Therapeutics all-time high annual stockholders equity is $124.70 M
What is AN2 Therapeutics annual shareholders equity year-on-year change?
Over the past year, ANTX annual stockholders equity has changed by +$29.33 M (+30.75%)
What is AN2 Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ANTX is $87.67 M
What is the all time high quarterly shareholders equity for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly stockholders equity is $138.97 M
What is AN2 Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ANTX quarterly stockholders equity has changed by -$22.93 M (-20.73%)